Neural control of blood pressure during pregnancy in humans.


Journal

Clinical autonomic research : official journal of the Clinical Autonomic Research Society
ISSN: 1619-1560
Titre abrégé: Clin Auton Res
Pays: Germany
ID NLM: 9106549

Informations de publication

Date de publication:
10 2020
Historique:
received: 25 03 2020
accepted: 10 06 2020
pubmed: 22 6 2020
medline: 25 11 2021
entrez: 22 6 2020
Statut: ppublish

Résumé

Previous microneurographic studies found that muscle sympathetic nerve activity (MSNA) increased in normotensive pregnant women and was even greater in women with gestational hypertension and preeclampsia during the third trimester. It is possible that sympathetic activation during the latter months of normal pregnancy helps return arterial pressure to non-pregnant levels. However, when the increase in sympathetic activity is excessive, hypertension ensues. The key question that must be addressed is whether sympathetic activation develops early during pregnancy and remains high throughout gestation, or whether this sympathetic overactivity only occurs at term, providing the substrate for preeclampsia and other pregnancy-associated cardiovascular complications. This was a literature review of autonomic neural control during pregnancy. Recent work from our laboratory and other laboratories showed that in healthy women resting MSNA increased in early pregnancy, increased further in late pregnancy, and returned to the pre-pregnancy levels shortly after delivery. We found that women who exhibited excessive sympathetic activation during the first trimester, before any clinical signs and symptoms appeared, developed gestational hypertension at term. We also found that the level of corin, an atrial natriuretic peptide-converting enzyme, was increased in the maternal circulation, especially during late pregnancy, as a homeostatic response to elevated sympathetic activity. These findings provide important insight into the neural mechanisms underlying hypertensive disorders during pregnancy. With this knowledge, early prevention or treatment targeted to the appropriate pathophysiology may be initiated, which may reduce maternal and fetal death or morbidity, as well as cardiovascular risks in women later in life.

Identifiants

pubmed: 32564162
doi: 10.1007/s10286-020-00703-3
pii: 10.1007/s10286-020-00703-3
pmc: PMC7572593
mid: NIHMS1605892
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

423-431

Subventions

Organisme : NHLBI NIH HHS
ID : R21 HL088184
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142605
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL075283
Pays : United States

Références

Am J Cardiol. 1997 Dec 1;80(11):1469-73
pubmed: 9399724
Hypertension. 1993 Dec;22(6):801-5
pubmed: 8244512
J Am Coll Cardiol. 2012 Oct 16;60(16):1558-65
pubmed: 23058313
Pregnancy Hypertens. 2018 Jan;11:1-6
pubmed: 29523263
Circulation. 2002 Aug 27;106(9):1116-20
pubmed: 12196338
Eur J Prev Cardiol. 2016 Nov;23(16):1755-1765
pubmed: 27378766
Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R587-R594
pubmed: 29897820
Am J Hypertens. 2003 Mar;16(3):194-9
pubmed: 12620697
Front Physiol. 2014 Mar 04;5:86
pubmed: 24624092
Obstet Gynecol. 2017 Aug;130(2):366-373
pubmed: 28697109
Heart. 2016 Apr;102(7):518-26
pubmed: 26794234
Placenta. 2013 Feb;34(2):89-94
pubmed: 23211473
Obstet Gynecol. 2005 Jul;106(1):156-61
pubmed: 15994632
Circulation. 1990 Jun;81(6):1860-73
pubmed: 2140540
Kidney Int. 1998 Dec;54(6):2056-63
pubmed: 9853271
BMC Med. 2017 Aug 8;15(1):148
pubmed: 28784170
Am J Obstet Gynecol. 2002 Mar;186(3):422-6
pubmed: 11904601
Hypertension. 2017 Oct;70(4):798-803
pubmed: 28893895
Am J Physiol Heart Circ Physiol. 2020 Apr 1;318(4):H816-H819
pubmed: 32142381
Hypertension. 1998 May;31(5):1065-9
pubmed: 9576115
J Biol Chem. 1999 May 21;274(21):14926-35
pubmed: 10329693
Pregnancy Hypertens. 2012 Jan;2(1):48-52
pubmed: 26104990
J Appl Physiol (1985). 2002 Feb;92(2):651-6
pubmed: 11796677
J Physiol. 2019 Jul;597(14):3687-3696
pubmed: 31106429
Am J Hypertens. 2012 Aug;25(8):892-9
pubmed: 22647784
Clin Auton Res. 2017 Dec;27(6):401-406
pubmed: 28674869
Am J Physiol. 1997 Feb;272(2 Pt 2):H748-52
pubmed: 9124434
Hypertension. 2001 Sep;38(3):379-83
pubmed: 11566908
J Womens Health (Larchmt). 2015 Jul;24(7):572-7
pubmed: 26086065
J Hypertens. 1998 May;16(5):617-24
pubmed: 9797173
Hypertension. 2015 Oct;66(4):858-64
pubmed: 26259593
Exp Physiol. 2018 Mar 1;103(3):318-323
pubmed: 29336094
Obstet Gynecol. 2013 Nov;122(5):1122-31
pubmed: 24150027
Am J Physiol Regul Integr Comp Physiol. 2018 Feb 1;314(2):R153-R160
pubmed: 29046311
Int J Cardiol. 2014 Oct 20;176(3):630-9
pubmed: 25213572
Matern Child Health J. 2012 Oct;16(7):1455-67
pubmed: 22105738
Nature. 2012 Mar 21;484(7393):246-50
pubmed: 22437503
Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H745-55
pubmed: 19151255
Br Heart J. 1992 Dec;68(6):540-3
pubmed: 1467047
Hypertens Pregnancy. 2020 May;39(2):117-125
pubmed: 32243195
J Clin Endocrinol Metab. 2017 Jun 1;102(6):2059-2068
pubmed: 28323975
Sci Rep. 2019 Dec 11;9(1):18847
pubmed: 31827184
BJOG. 2000 Jan;107(1):116-21
pubmed: 10645870
Semin Reprod Med. 2009 Jul;27(4):330-7
pubmed: 19530067
Circulation. 2001 Oct 30;104(18):2200-4
pubmed: 11684631
Am J Obstet Gynecol. 2019 Dec;221(6):631.e1-631.e16
pubmed: 31283904
Sci Rep. 2015 Nov 26;5:16834
pubmed: 26607032
Hypertension. 1995 Apr;25(4 Pt 1):631-6
pubmed: 7721408
J Physiol. 2015 Mar 1;593(5):1159-68
pubmed: 25545472
Hypertension. 2019 Feb;73(2):432-439
pubmed: 30580684
J Physiol. 2006 Dec 1;577(Pt 2):679-87
pubmed: 17008377
J Appl Physiol (1985). 2015 Sep 1;119(5):468-74
pubmed: 26139215
N Engl J Med. 1996 Nov 14;335(20):1480-5
pubmed: 8890098
Eur J Clin Invest. 2004 Jun;34(6):443-8
pubmed: 15200497
Ultrasound Obstet Gynecol. 2015 Feb;45(2):190-8
pubmed: 25296530
Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H782-H787
pubmed: 28733450
Placenta. 2016 Dec;48:20-25
pubmed: 27871468
Am J Obstet Gynecol. 2000 Dec;183(6):1489-94
pubmed: 11120516
J Physiol. 2012 Aug 1;590(15):3535-43
pubmed: 22687610

Auteurs

Sarah L Hissen (SL)

Women's Heart Health Laboratory, Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, 7232 Greenville Avenue, Suite 435, Dallas, TX, 75231, USA.
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA.

Qi Fu (Q)

Women's Heart Health Laboratory, Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, 7232 Greenville Avenue, Suite 435, Dallas, TX, 75231, USA. QiFu@TexasHealth.org.
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. QiFu@TexasHealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH